Copyright
©The Author(s) 2019.
World J Diabetes. Mar 15, 2019; 10(3): 189-199
Published online Mar 15, 2019. doi: 10.4239/wjd.v10.i3.189
Published online Mar 15, 2019. doi: 10.4239/wjd.v10.i3.189
Estimate | Se | Lower limit | Upper limit | Z stat | P-value | |
Univariate model (exchangeable correlation) | ||||||
White | 1.26 | 0.88 | -0.47 | 2.98 | 1.43 | 0.154 |
Female | 0.5433 | 0.3674 | -0.1768 | 1.2635 | 1.48 | 0.1392 |
Age | -0.0046 | 0.0097 | -0.0236 | 0.0144 | -0.47 | 0.6355 |
Gastrointestinal (GI) symptoms | 0.2551 | 0.3395 | -0.4103 | 0.9206 | 0.75 | 0.4524 |
Extraintestinal (EX) symptoms | -0.3748 | 0.4596 | -1.2756 | 0.526 | -0.82 | 0.4148 |
Both GI and EX symptoms | -0.2715 | 0.5305 | -1.3113 | 0.7682 | -0.51 | 0.6087 |
No GI or EX symptoms | -0.085 | 0.3419 | -0.7551 | 0.5851 | -0.25 | 0.8036 |
Human Leukocyte Antigen (HLA) DQ2-DR3 Heterozygous | 0.4255 | 0.383 | -0.3251 | 1.1761 | 1.11 | 0.2666 |
HLA DQ2-DR3 Homozygous | 0.8042 | 0.7654 | -0.696 | 2.304 | 1.05 | 0.2934 |
HLA DQ2-DR7 Heterozygous | -0.0376 | 0.6636 | -1.3382 | 1.263 | -0.06 | 0.9548 |
HLA DQ2-DR3/DR7 Homozygous | 1.02 | 0.715 | -0.381 | 2.42 | 1.43 | 0.153 |
HLA DQ8 | -0.0981 | 0.4058 | -0.8934 | 0.6972 | -0.24 | 0.809 |
HLA DQ2-DR3/DQ8 | 0.9272 | 0.472 | 0.0021 | 1.8523 | 1.96 | 0.0495A |
HLA DQ2/DQ8 Negative | -2.1836 | 1.0232 | -4.1891 | -0.1781 | -2.13 | 0.0328B |
HLA DQ2 Heterozygous | 0.3561 | 0.388 | -0.4043 | 1.1166 | 0.92 | 0.3586 |
HLA DQ2 Homozygous | 0.6842 | 0.5435 | -0.3811 | 1.7495 | 1.26 | 0.2081 |
Haptoglobin genotype (HP) 1-1 | 0.2901 | 0.4341 | -0.5607 | 1.1409 | 0.67 | 0.5039 |
HP 2-1 | 0.6823 | 0.3429 | 0.0103 | 1.3544 | 1.99 | 0.0466C |
HP 2-2 | -1.0763 | 0.4252 | -1.9096 | -0.2429 | -2.53 | 0.0114D |
Any HP2 | -0.29 | 0.434 | -1.141 | 0.561 | -0.67 | 0.503 |
First degree relative (FDR) with CDceliac disease (CD) | 1.6768 | 0.3809 | 0.9303 | 2.4233 | 4.4 | <.0001E |
FDR with thyroid disease | -0.503 | 0.4849 | -1.4533 | 0.4473 | -1.04 | 0.2995 |
FDR with other autoimmune disease | 0.6817 | 0.3606 | -0.025 | 1.3884 | 1.89 | 0.0587 |
CD in other relative | 0.5217 | 0.7115 | -0.8728 | 1.9161 | 0.73 | 0.4634 |
Multiple regression model (independence working correlation) | ||||||
Intercept | -2.8829 | 0.404 | -3.6746 | -2.0912 | -7.14 | < 0.0001 |
HLA DQ2-DR3/DQ8 | 0.9407 | 0.5381 | -0.1139 | 1.9953 | 1.75 | 0.0804 |
HLA DQ2/DQ8 Negative | -1.9348 | 1.0275 | -3.9487 | 0.0791 | -1.88 | 0.0597 |
HP 2-1 | 0.0804 | 0.4492 | -0.8001 | 0.9609 | 0.18 | 0.858 |
HP 2-2 | -1.0149 | 0.563 | -2.1185 | 0.0886 | -1.8 | 0.0715 |
FDR with CD | 2.3635 | 0.7576 | 0.8787 | 3.8483 | 3.12 | 0.0018F |
FDR with other autoimmune disease | -0.8269 | 0.7245 | -2.2468 | 0.5932 | -1.14 | 0.2538 |
- Citation: Leonard MM, Camhi S, Kenyon V, Betensky RA, Sturgeon C, Yan S, Fasano A. Targeted genotyping for the prediction of celiac disease autoimmunity development in patients with type 1 diabetes and their family members. World J Diabetes 2019; 10(3): 189-199
- URL: https://www.wjgnet.com/1948-9358/full/v10/i3/189.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i3.189